Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 20
- Registration Number
- NCT06495944
- Locations
- 🇺🇸
Site 01, Baltimore, Maryland, United States
A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 195
- Registration Number
- NCT06108219
- Locations
- 🇺🇸
Site #475, Largo, Florida, United States
🇺🇸Site #207, Chandler, Arizona, United States
🇺🇸Site #209, Tucson, Arizona, United States
A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 8
- Registration Number
- NCT06094712
- Locations
- 🇺🇸
Jasper Clinic, Kalamazoo, Michigan, United States
A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 32
- Registration Number
- NCT06094790
- Locations
- 🇺🇸
Quotient Sciences, Miami, Inc., Miami, Florida, United States
A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT06094738
- Locations
- 🇺🇸
inVentiv Health Clinical Research Services LLC, Miami, Florida, United States
A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT06094725
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, LLC, Miami, Florida, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
- Conditions
- Interventions
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 1000
- Registration Number
- NCT05772169
- Locations
- 🇺🇸
Site 375, Torrance, California, United States
🇺🇸Site 410, Baltimore, Maryland, United States
🇺🇸Site 070, Albany, New York, United States
Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant
- Conditions
- Interventions
- First Posted Date
- 2023-02-03
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 26
- Registration Number
- NCT05712265
- Locations
- 🇺🇸
Site 01, Miami, Florida, United States
Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 36
- Registration Number
- NCT05553470
- Locations
- 🇺🇸
Site 02, Miami Lakes, Florida, United States
🇺🇸Site 01, Miami, Florida, United States
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 249
- Registration Number
- NCT05407324
- Locations
- 🇨🇦
425, Hamilton, Ontario, Canada
🇫🇷261, Marseille, France
🇧🇪108, Leuven, Belgium